LISATA THERAPEUTICS, INC. Proceeds from Long-Term Debt Issued
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2016-03-15
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2014-12-31 was $523.83K.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2014 was $15.00M.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2013 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from issuance of long-term debt for fiscal 2012 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | ||
| 2014-12-31 | $523.83K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $15.00M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $14.48M 10-Q · filed 2015-11-05 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-10-30 | ||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |